38MO Validation study of the ShallowHRDv2 assay for homologous recombination deficiency (HRD) detection in high-grade ovarian carcinomas (HGOC) in the first-line setting, from the phase III PAOLA-1/ENGOT-ov25 trial
| Autor: | Callens, C., Rodrigues, M.J., Briaux, A., Browaeys, E., Eeckhoutte, A., Pujade-Lauraine, E., Renault, V., Stoppa-Lyonnet, D., Bieche, I., Bataillon, G., Heitz, F., Chiara-Cecere, S., Rubio Perez, M.J., Berger, R., Jakobi Nøttrup, T., Colombo, N., Vergote, I.B., Ray-Coquard, I.L., Stern, M-H., Popova, T. |
|---|---|
| Zdroj: | In ESMO Open February 2023 8(1) Supplement 1 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|